Bioregenx BRGX
OTC BRGX
$0.00 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Bioregenx, Inc. (BRGX) Notes Payables (2022 - 2023)

Updated

Bioregenx (BRGX) reported Notes Payables of $25,370 for Q4 2023, down 38.1% from $40,970 a year earlier but up 76.3% from the prior quarter.

Analysis

Bioregenx, Inc. (BRGX) Notes Payables (2022 - 2023) Analysis & Trends

Dating back to Q4 2022, Bioregenx's Notes Payables record includes 5 quarters.

  • By year, Notes Payables came in at $40,970 in FY2022.
  • Five-year quarterly Notes Payables spans a low of $12,590 in Q1 2023 and a high of $40,970 in Q4 2022.
  • Per Business Quant data, the three quarters before Q4 2023 came in at $14,390 (Q3 2023), $12,590 (Q2 2023) and $12,590 (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 25,370.00
Sep 30, 2023 14,390.00
Jun 30, 2023 12,590.00
Mar 31, 2023 12,590.00
Dec 31, 2022 40,970.00
API Access

Bioregenx, Inc. Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BRGX&period=max&api_key=YOUR_API_KEY